|
|
Article: Genzyme, Inamed Receive Approval For Dermal Filler.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
Genzyme Corp. and its exclusive worldwide partner, Inamed Corp., won FDA approval to market Hylaform gel as a nonsurgical dermal filler for moderate to severe facial wrinkles and folds.
Cambridge, Mass.-based Genzyme will manufacture the gel while Santa Barbara, Calif.-based Inamed will be responsible for marketing and distribution. Financially, Genzyme is poised to earn a milestone on regulatory clearance and undisclosed royalties on sales.
Hylaform will be launched immediately.
While Genzyme doesn't commonly work in the cosmetic arena, Dan Quinn, company spokesman, told BioWorld Today the firm is in on the deal ...